California Kidney Specialists
San Dimas, California 91773-3537
0 studies enrolling now · 10 studies all time
What they study most
Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD), Clostridium Difficile Infection, Diabetic Kidney Disease, Diabetic Nephropathies, Diabetic Nephropathy, Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention, Kidney Disease, Chronic, Lupus Nephritis, Resistant Hypertension, Type 2 Diabetes Mellitus With Diabetic Nephropathy
Studies at this site
- The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
- A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine (ExPEC9V) in the Prevention of Invasive Extraintestinal Pathogenic Escherichia Coli Disease in Adults Aged 60 Years And Older With a History of Urinary Tract Infection in the Past 2 Years — Completed
- Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) — Stopped early
- A Study to Test Whether Different Doses of BI 690517 Alone or in Combination With Empagliflozin Improve Kidney Function in People With Chronic Kidney Disease — Completed
- A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety — Completed
- Clostridium Difficile Vaccine Efficacy Trial — Completed
- A Study to Evaluate the Soluble Guanylate Cyclase (sGC) Stimulator IW-1973 in Diabetic Nephropathy / Diabetic Kidney Disease as Measured by Albuminuria — Completed
- Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria — Completed
- A Phase 2, Placebo-Controlled Study To Evaluate The Efficacy And Safety Of PF-00489791 In Patients With Type 2 Diabetes And Overt Nephropathy — Completed
- A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy — Completed